日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acetyl-CoA acyltransferase 2 palmitoylation drives liver fibrosis by inducing hepatic stellate cell ferroptosis

乙酰辅酶A酰基转移酶2棕榈酰化通过诱导肝星状细胞铁死亡促进肝纤维化。

Han, Jianxiong; Yan, Zhongkang; Sun, Zhiran; Dang, Wenyuan; Li, Bao; Li, Shuangshuang; Lv, Xinru; Ni, Lin; He, Anyuan; Gu, Pengying; Wang, Feifei; Wang, Lili; Yang, Xingyuan

Peroxisomal metabolism of branched fatty acids regulates energy homeostasis

过氧化物酶体对支链脂肪酸的代谢调节能量稳态

Liu, Xuejing; He, Anyuan; Lu, Dongliang; Hu, Donghua; Tan, Min; Abere, Abenezer; Goodarzi, Parniyan; Ahmad, Bilal; Kleiboeker, Brian; Finck, Brian N; Zayed, Mohamed; Funai, Katsuhiko; Brestoff, Jonathan R; Javaheri, Ali; Weisensee, Patricia; Mittendorfer, Bettina; Hsu, Fong-Fu; Van Veldhoven, Paul P; Razani, Babak; Semenkovich, Clay F; Lodhi, Irfan J

Hepatic HSD17B6 is dispensable for diet-induced fatty liver disease in mice.

肝脏 HSD17B6 对于小鼠饮食诱导的脂肪肝疾病并非必需

Yuan Delong, Bai Nan, Zhu Qihan, Song Shaoxuan, He Anyuan, Wang Jianqing, Chen Yali

Letter regarding 'mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome'

关于“线粒体酰胺肟还原成分 1 p.Ala165Thr 增加蛋白酶体介导的蛋白质降解”的信函

Tie, Meng; Ferguson, Daniel; Chen, Yali; He, Anyuan

Fatty liver disease protective MTARC1 p.A165T variant reduces the protein stability of MTARC1.

脂肪肝疾病保护性MTARC1 p.A165T变体降低了MTARC1的蛋白质稳定性

Wu Mengyue, Tie Meng, Hu Liwei, Yang Yunzhi, Chen Yong, Ferguson Daniel, Chen Yali, He Anyuan

Peroxisomes as cellular adaptors to metabolic and environmental stress

过氧化物酶体作为细胞适应代谢和环境压力的调节器

He, Anyuan; Dean, John M; Lodhi, Irfan J

Lipid Regulators of Thermogenic Fat Activation

脂质调节因子对产热脂肪活化的影响

Park, Hongsuk; He, Anyuan; Lodhi, Irfan J

PexRAP Inhibits PRDM16-Mediated Thermogenic Gene Expression.

PexRAP抑制PRDM16介导的产热基因表达

Lodhi Irfan J, Dean John M, He Anyuan, Park Hongsuk, Tan Min, Feng Chu, Song Haowei, Hsu Fong-Fu, Semenkovich Clay F